Athira Sethu
Kochi, 2 Feb 2026
Sun Pharmaceuticals’ share price is trading higher on Monday after the company posted strong set of Q3FY26 numbers. The leading pharma company reported robust financial performance for the third quarter of FY26, with a notable 16% year-on-year growth in net profit. The company posted a net profit of Rs 3,368.8 crore, up from Rs 2,903 crore in the same period last year. Sun Pharma also announced an interim dividend of Rs 11 per equity share of Rs 1 each for FY26. The record date for the dividend is set for February 5, 2026, with the payout scheduled to be made on or before February 16, 2026.
Here is a snapshot:
| Parameter | Q3 FY26 | Q3 FY25 | YoY Change |
| Net Profit | Rs 3,368.8 crore | Rs 2,903 crore | 16% |
| Revenue from Operations | Rs 15,520.5 crore | Rs 13,668.3 crore | 13.5% |
| Sales | Rs 15,469.1 crore | Rs 13,433 crore | 15.1% |
| EBITDA | Rs 4,984.4 crore | Rs 4,009 crore | 23.4% |
| Operating Margin | 31.9% | 29.3% | 2.6% increase |
| Exceptional Items | Rs 489.4 crore | – | – |
| Key Highlights | Details |
| Global Innovative Medicines Sales | $423 million |
| Milestone Payment (Part of above) | $55 million |
| Excluding Milestone Growth in Sales | 13.2% |
| Contribution to Overall Sales | 21.2% |
| Dividend Information | Details |
| Interim Dividend Per Share | Rs 11 per equity share |
| Record Date for Dividend | February 5, 2026 |
| Payout Date | On or before February 16, 2026 |
 Disclaimer: This information is for educational purposes only.
